Farley Dillinger Team Johnson & Johnson

How did you get involved with the MMRF?

I was introduced to MMRF through a fellow J&J  employee, Matt Stella.   In 2020 at a chance meeting we discussed cycling and he told me that he was participating in the MMRF ride.  I expressed an interest and learned there was still a spot on the team and joined. Due to COVID the ride didn’t happen until 2022 in Maine, and it was awesome.

 What do you want people to know about multiple myeloma?

I want people to know that there have been great strides made in the treatment of multiple myeloma. In fact, I have met people who would not be alive today,  but for recently developed treatments including some from my company J&J.

Why is participating in the MMRF Road to Victories ride important to you?

I want to help find a cure for multiple myeloma.

What are you looking most forward to/excited about the ride?

The fellowship, the camaraderie, the experience of riding wine country all while making a difference.

What does your training regimen for this event look like?

I ride outside every chance I get. I try to ride at least 100+ miles per week.

Who/what inspires you?

Every patient that I met on the ride. They have incredible courage and determination.

Have you participated in previous MMRF events? If so, which/when?

Yes, Maine in 2022.


Sorry, there are no posts from this member.
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit www.themmrf.org.

Learn More

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more About Johnson & Johnson inovative medicine Learn more About Johnson & Johnson Follow us on @JanssenUS And @JNJInnovMed